Delivery Order SPE2DX22D0010-SPE2D825FFU64
Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vyvanse capsules 70mg, with a ceiling value of $9,638.76. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's competitive...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Vyvanse 10 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $13,567.08 and is structured as a firm fixed price delivery order, with an ultimate completion date of May 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $16,827.85 for Vyvanse capsules 70mg on June 16, 2025, with completion expected by June 17, 2025. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,658.76 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (30 mg) on August 20, 2025. This firm fixed-price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, leveraging...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on May 6, 2025, for Vyvanse Caps 30mg with a ceiling value of $31,382.02 under a firm fixed-price arrangement. This non-set-aside award, due for completion by May 7, 2025, represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vyvanse 50 mg capsules (100-count units) at a firm fixed price with a ceiling value of $10,200.12. This competitively awarded, non-set-aside contract is scheduled for completion by July 24, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Vyvanse capsules 50mg under a firm fixed-price contract with a ceiling value of $18,338.85. This competitive award, executed without a set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $4,698.42. This non-competitive delivery order represents a firm fixed price transaction with a completion date of September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on March 18, 2025, for the supply of Vyvanse capsules 40mg, with a contract ceiling value of approximately $30K and an ultimate completion date of March 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Department of Defense's Medical Supply Chain awarded a $54.8K delivery order to AmerisourceBergen Drug Corp for supply of Vyvanse capsules (30mg) under a firm fixed-price contract. The delivery order, issued on September 11, 2025, with completion targeted for September 12, 2025, was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains substantial pharmaceutical...